If we build it they will come: targeting the immune response to breast cancer

Historically, breast cancer tumors have been considered immunologically quiescent, with the majority of tumors demonstrating low lymphocyte infiltration, low mutational burden, and modest objective response rates to anti-PD-1/PD-L1 monotherapy. Tumor and immunologic profiling has shed light on poten...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:NPJ Breast Cancer
Main Authors: Gatti-Mays, Margaret E., Balko, Justin M., Gameiro, Sofia R., Bear, Harry D., Prabhakaran, Sangeetha, Fukui, Jami, Disis, Mary L., Nanda, Rita, Gulley, James L., Kalinsky, Kevin, Abdul Sater, Houssein, Sparano, Joseph A., Cescon, David, Page, David B., McArthur, Heather, Adams, Sylvia, Mittendorf, Elizabeth A.
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group UK 2019
Assuntos:
Review Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6820540/
https://ncbi.nlm.nih.gov/pubmed/31700993
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41523-019-0133-7
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados